ADAMIS PHARMACEUTICALS CORP's ticker is and the CUSIP is 00547W958. A total of 3 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | -95.5% | 1,500 | -95.8% | 0.00% | – |
| Q4 2021 | $22,000 | -57.7% | 36,100 | -32.3% | 0.00% | – |
| Q3 2021 | $52,000 | -79.9% | 53,300 | -77.3% | 0.00% | – |
| Q2 2021 | $259,000 | +123.3% | 235,100 | +89.7% | 0.00% | – |
| Q1 2021 | $116,000 | – | 123,900 | +123800.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 100 | -98.8% | 0.00% | – |
| Q3 2019 | $6,000 | -89.7% | 8,000 | -82.1% | 0.00% | -100.0% |
| Q2 2019 | $58,000 | -60.3% | 44,800 | -35.4% | 0.00% | -50.0% |
| Q1 2019 | $146,000 | -43.4% | 69,400 | -39.5% | 0.00% | 0.0% |
| Q4 2018 | $258,000 | -47.7% | 114,700 | -18.6% | 0.00% | -50.0% |
| Q3 2018 | $493,000 | +1073.8% | 140,900 | +983.8% | 0.00% | – |
| Q2 2018 | $42,000 | -50.0% | 13,000 | -45.8% | 0.00% | -100.0% |
| Q1 2018 | $84,000 | -35.9% | 24,000 | -19.2% | 0.00% | 0.0% |
| Q4 2017 | $131,000 | +104.7% | 29,700 | +143.4% | 0.00% | 0.0% |
| Q3 2017 | $64,000 | -72.1% | 12,200 | -72.3% | 0.00% | -50.0% |
| Q2 2017 | $229,000 | +940.9% | 44,100 | +764.7% | 0.00% | – |
| Q1 2017 | $22,000 | -60.7% | 5,100 | -68.9% | 0.00% | -100.0% |
| Q3 2016 | $56,000 | +75.0% | 16,400 | +43.9% | 0.00% | – |
| Q2 2016 | $32,000 | +1500.0% | 11,400 | +2180.0% | 0.00% | – |
| Q2 2015 | $2,000 | -85.7% | 500 | -85.7% | 0.00% | – |
| Q1 2015 | $14,000 | +16.7% | 3,500 | +75.0% | 0.00% | – |
| Q4 2014 | $12,000 | +140.0% | 2,000 | +100.0% | 0.00% | – |
| Q3 2014 | $5,000 | -50.0% | 1,000 | -50.0% | 0.00% | – |
| Q2 2014 | $10,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 111 | $8,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |